Ted Karkus - 16 Oct 2022 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
CEO & CHAIRMAN, Director, 10%+ Owner
Signature
/s/ Ted Karkus
Issuer symbol
PRPH
Transactions as of
16 Oct 2022
Transactions value $
-$2,942,999
Form type
4
Filing time
18 Oct 2022, 09:34:07 UTC
Previous filing
10 Aug 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRPH Common Stock, par value $0.005 Options Exercise $360,000 +600,000 +22% $0.6* 3,388,609 16 Oct 2022 Direct F1
transaction PRPH Common Stock, par value $0.005 Tax liability -$3,302,999 -317,291 -9.4% $10.41 3,071,318 16 Oct 2022 Direct F1
holding PRPH Common Stock, par value $0.005 100,000 16 Oct 2022 By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Options Exercise $0 -600,000 -35% $0 1,100,000 16 Oct 2022 Common Stock 600,000 $0.6 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 16, 2022, the Reporting Person acquired net 282,709 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 317,291 shares of common stock withheld to cover the exercise price and applicable taxes.
F2 The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.